JinkoSolar (JKS) Announces Proposed At-the-Market ADS Offering Up to $100M
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- S&P 500, Nasdaq fall, dragged by Alphabet and megacap tech; focus on Iran
- Oil falls almost 4% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Needham Starts NeoVolta (NEOV) at Buy
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- Companies to add 40 million barrels of oil to US SPR after Iran war ends, energy secretary says
- China makes small dent in deflation battle as supply-demand imbalance persists
CICC Downgrades JinkoSolar Holding Co., Ltd. (JKS) to
December 9, 2020 4:30 AM ESTCICC analyst Jun Liu downgraded JinkoSolar Holding Co., Ltd. (NYSE: JKS) from Outperform to (from $58.00).
For an analyst ratings summary and ratings history on JinkoSolar Holding Co., Ltd. click here. For more ratings news on JinkoSolar Holding Co., Ltd. click here.
Shares of JinkoSolar Holding Co., Ltd. closed at $62.42 yesterday.
... MoreJinkoSolar (JKS) Announces Changes to Board of Directors
December 8, 2020 6:15 AM ESTJinkoSolar Holding Co., Ltd. (the "Company," or "JinkoSolar") (NYSE: JKS), one of the largest and most innovative solar module manufacturers in the world, today announced changes to its board of directors (the "Board"). Mr. Longgen Zhang has resigned as a director of... More
Pre-Open Stock Movers 12/07: (KODK) (CKH) Higher; (RIDE) (XPEV) (JKS) Lower (more...)
December 7, 2020 9:26 AM ESTToday's Pre-Open Stock Movers
Eastman Kodak Company (NYSE: KODK) 72% HIGHER; news that federal regulators found no wrongdoing in getting a loan from the government.
Kura Oncology, Inc. (Nasdaq: KURA) 16.9% HIGHER; announced preliminary clinical data from KOMET-001, an ongoing Phase 1/2A clinical trial of the Companys oral, potent and selective menin inhibitor, KO-539, including single-agent activity in genetically defined subgroups of patients with relapsed or refractory acute myeloid leukemia (AML).
Matinas BioPharma Holdings, Inc. (NYSE:... More
JinkoSolar (JKS) Tops Q3 EPS by 21c, Q4 Revenue Guidance Misses
December 7, 2020 7:45 AM ESTJinkoSolar (NYSE: JKS) reported Q3 EPS of $1.06, $0.21 better than the analyst estimate of $0.85. Revenue for the quarter came in at $1.29 billion versus the consensus estimate of $1.3 billion.
GUIDANCE:
JinkoSolar sees Q4 2020 revenue of $1.31-1.43 billion, versus the consensus of $1.52... More
